Symbol="HARP"
AssetType="Common Stock"
Name="Harpoon Therapeutics Inc"
Description="Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, is involved in the development of a new class of T-cell activators that harness the power of the body's immune system to treat patients with cancer and other diseases in the United States. . The company is headquartered in South San Francisco, California."
CIK="1708493"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="131 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="31580500"
EBITDA="-56362000"
PERatio="None"
PEGRatio="None"
BookValue="0.019"
DividendPerShare="0"
DividendYield="0"
EPS="-2"
RevenuePerShareTTM="1.012"
ProfitMargin="-1.698"
OperatingMarginTTM="-1.699"
ReturnOnAssetsTTM="-0.344"
ReturnOnEquityTTM="-2.791"
RevenueTTM="34592000"
GrossProfitTTM="-49478000"
DilutedEPSTTM="-2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.453"
AnalystTargetPrice="5.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.746"
PriceToBookRatio="1.493"
EVToRevenue="0.587"
EVToEBITDA="0.433"
Beta="1.535"
num_52WeekHigh="2.76"
num_52WeekLow="0.544"
num_50DayMovingAverage="0.72"
num_200DayMovingAverage="0.797"
SharesOutstanding="37595800"
DividendDate="None"
ExDividendDate="None"
symbol="HARP"
open="0.85"
high="0.87"
low="0.81"
price="0.84"
volume="198128.00"
latest_trading_day="2023-07-11"
previous_close="0.84"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="47"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="240038"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.91"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="493"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_negative_thumbnail_id_2="494"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0111.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="557"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_positive_thumbnail_id_1="677"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0031.jpeg"
image_positive_thumbnail_id_2="621"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0087.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
